Hereditary diffuse gastric cancer: genetic aspects and prophylactic total gastrectomy

Автор: Lyubchenko Liudmila N., Filippova Margarita G., Anurova Olga A., Nazliev Pavel B., Stilidi Ivan S.

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Клинические исследования

Статья в выпуске: 4 т.17, 2018 года.

Бесплатный доступ

For patients with an identified germline E-cadherin-1 ( CDH1 ) mutation, prophylactic gastrectomy is the treatment of choice to eliminate the high risk of developing diffuse gastric cancer. The case report describes a rare case of hereditary diffuse gastric cancer (HDgC) associated with CDH1 gene mutation, which is reported in the Russian population for the first time. In 2013, a 28-year-old woman was referred to Clinical Oncogenetics Laboratory with a family history of gastric cancer. Molecular genetic analysis revealed CDH1 gene mutation. The lifetime risk of cancer in mutation positive members is more than 80. Histological examination of gastric biopsy specimens obtained during endoscopy revealed isolated signet ring cells in the lamina propria. Spleen-preserving D2-lymphodissection and total gastrectomy with Roux-en-Y reconstruction with a jejunal reservoir formation were performed at the Abdominal Oncology Surgery Department.

Еще

Hereditary diffuse gastric cancer (hdgc), cdh1 gene, gastrectomy, molecular genetic diagnostics

Короткий адрес: https://sciup.org/140254198

IDR: 140254198   |   DOI: 10.21294/1814-4861-2018-17-4-48-52

Список литературы Hereditary diffuse gastric cancer: genetic aspects and prophylactic total gastrectomy

  • Le Vecchia C., Negri E., Franceeschi S., Gentile A. Family history and risk of stomach and colorectal canser. Canser. 1992; 70: 50-58.
  • Caldas C., Carneiro F., Lynch H.T., Yokota J., Wiesner G.L., Powell S.M., Lewis F.R., Huntsman D.G., Pharoah P.D., Jankowski J.A., MacLeod P., Vogelsang H., Keller G., Park K.G., Richards F.M., Maher E.R., Gayther S.A., Oliveira C., Grehan N., Wight D., Seruca R., Roviello F., Ponder B.A., Jackson C.E. Family gastric canser: overview and guidelines for management. J Med Genet. 1999; 36: 873-80.
  • Fitzgerald R.C., Hardwick R., Huntsman D., Carneiro F., Guilford P., Blair V., Chung D.C., Norton J., Ragunath K., Van Krieken J.H., Dwerryhouse S., Caldas C.; International Gastric Cancer Linkage Consortium. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010 Jul; 47(7): 436-44. DOI: 10.1136/jmg.2009.074237
  • Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A.E. E-cadgerin germline mutations in familiar gastric cancer. Nature. 1998; 392: 402-405.
  • Corso G., Marrelli D., Pascale V., Vindigni C., Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and lo-risk areas: metanalysis and systematic rewiew of the literature. BMC Canser. 2012; 2: 8.
Еще
Статья научная